Dr. Armen Khachatryan at The Disc Replacement Center, in Salt Lake City, UT, is currently the leading enroller for the single-level trial, and Dr. Hyun Bae at the Foundation for Spinal Restoration in Santa Monica, CA, is the leading enroller for the two-level trial. Investigational Device Exemption (IDE) Clinical Trials of the BAGUERA® C Cervical Disc Prosthesis. announced today that the 100 th surgery has been performed in their combined single-level and two-level U.S. 16, 2021 /PRNewswire/ - Spineart USA Inc. ORHub Enters The Holidays, Generating Revenue Through Continued Customer Agreement.
The Christ Hospital Health Network Partners with IncludeHealth to Bring Physical Therapy into Patients’ Homes.Kristine Johnson and Kristina Wright to its Board of Directors Using Pixee Medical’s Knee+ Augmented-Reality Platform MicroPort Orthopedics Announces First Successful Total Knee Replacement Performed in the U.S.Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products.Spine Wave Announces the Commercial Launch of the Defender® Anterior Cervical Plate and the Stronghold® C 3D Titanium Interbody Device.CoreLink Announces Commercial Launch Of CentraFix™ Midline Fixation System.Providers slam House for not delaying nearly 10% Medicare payment cuts in must-pass spending deal.AxioMed LLC Reports Landmark Filing of Initial PMA Module to FDA as the First Viscoelastic Lumbar Artificial Disc Replacement to Complete an IDE Clinical Study.
0 kommentar(er)
